Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

A new familial variant of antithrombin III: 'antithrombin III Paris'.

Wolf M, Boyer C, Lavergne JM, Larrieu MJ.

Br J Haematol. 1982 Jun;51(2):285-95.

PMID:
7082587
2.

A tentative classification of AT III congenital abnormalities.

Girolami A.

Folia Haematol Int Mag Klin Morphol Blutforsch. 1987;114(5):661-9. Review.

PMID:
2448207
3.

[Familial antithrombin III abnormality accompanied with progressing ischemic stroke].

Sasaki Y, Ueyama H, Hashimoto Y, Uchino M, Araki S.

Rinsho Shinkeigaku. 1989 Apr;29(4):450-5. Review. Japanese.

PMID:
2692932
4.

[Acquired antithrombin III deficiency].

Müller G.

Z Gesamte Inn Med. 1992 Feb;47(2):74-7. Review. German.

PMID:
1585693
5.

Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency. An update.

Rodgers GM.

Thromb Haemost. 2009 May;101(5):806-12. Review.

PMID:
19404531
6.
7.

Antithrombin III. A review.

Mortensen JZ, Jørgensen KA.

Dan Med Bull. 1983 Mar;30(2):100-5. Review. No abstract available.

PMID:
6342984
8.

[The physiological inhibitors of blood coagulation. 1. Antithrombin III (AT III)].

Kase F, Pospísil J.

Folia Haematol Int Mag Klin Morphol Blutforsch. 1983;110(3):337-49. Review. German.

PMID:
6194066
9.

Molecular genetics of antithrombin deficiency.

Lane DA, Kunz G, Olds RJ, Thein SL.

Blood Rev. 1996 Jun;10(2):59-74. Review.

PMID:
8813337
10.

Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism.

Kuhle S, Lane DA, Jochmanns K, Male C, Quehenberger P, Lechner K, Pabinger I.

Thromb Haemost. 2001 Oct;86(4):1007-11. Review.

PMID:
11686316
11.

Antithrombin: molecular basis of deficiency.

Bayston TA, Lane DA.

Thromb Haemost. 1997 Jul;78(1):339-43. Review.

PMID:
9198176
12.

[Congenital antithrombin III deficiency associated with pulmonary thromboembolism].

Katayama T, Akiba Y, Nishigaki Y, Morimoto H, Yamaguchi S, Fujiuchi S, Yamazaki Y, Nakano H, Ohsaki Y, Kikuchi K.

Nihon Kyobu Shikkan Gakkai Zasshi. 1997 Jul;35(7):790-5. Review. Japanese.

PMID:
9341285
13.

Antithrombin III deficiency.

Beresford CH.

Blood Rev. 1988 Dec;2(4):239-50. Review.

PMID:
3061530
14.

[Acquired and congenital antithrombin III deficiency. Discussion of a clinical case].

De Blasio F, De Filippis R, Bucci N, Formato A, Pezza A.

Arch Monaldi Mal Torace. 1987 Mar-Apr;42(2):205-13. Review. Italian. No abstract available.

PMID:
3333220
15.

Laboratory evaluation of antithrombin III: a critical overview of currently available methods for antithrombin III measurements.

Fareed J, Messmore HL, Walenga JM, Bermes EW, Bick RL.

Semin Thromb Hemost. 1982 Oct;8(4):288-301. Review. No abstract available.

PMID:
6817417
16.

[Heparin cofactor II studies in thrombophilic patients].

Pál A, Sas G.

Orv Hetil. 1990 Mar 4;131(9):461-2, 465. Review. Hungarian.

PMID:
2179813
17.

Congenital and acquired defects of antithrombin III.

Sas G.

Ric Clin Lab. 1984 Jul-Sep;14(3):491-7. Review. No abstract available.

PMID:
6395295
18.

Role of antithrombin III as a regulator of in vivo coagulation.

Bauer KA, Rosenberg RD.

Semin Hematol. 1991 Jan;28(1):10-8. Review. No abstract available.

PMID:
2017686
19.

Congenital deficiencies of anticoagulant proteins (antithrombin III and protein C).

Mannucci PM, Tripodi A, Mari D.

Haematologica. 1984 Nov-Dec;69(6):730-46. Review. No abstract available.

PMID:
6441751
20.

Replacement therapy in patients with hereditary antithrombin III deficiency.

Menache D.

Semin Hematol. 1991 Jan;28(1):31-8. Review. No abstract available.

PMID:
2017690

Supplemental Content

Support Center